Low Dose Ketamine VR Analgesia During Burn Care Procedure

Low Dose Ketamine to Enhance VR Analgesia During Painful Burn Care Procedure.

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01889537

Acronym

VRK

Enrollment

Registered

2013-06-28

Start date

2012-07-31

Completion date

2015-06-30

Last updated

2017-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn

Keywords

Virtual Reality Ketamine

Brief summary

The purpose of the research is to see whether a low dose of ketamine, a medication used to reduce pain, enhances the effectiveness of a virtual reality video game, which is used as a form of distraction from pain during a painful burn care procedure.

Detailed description

This study is conducted in a hospital setting. It is a randomized controlled trial comparing the use of virtual reality distraction (VRD) and standard pain medications to the use of VRD, standard pain medications and a single low dose of ketamine as a means to reduce pain during a painful procedure in patients in the hospital.

Interventions

BEHAVIORALVirtual Reality

The patient will receive virtual reality during a burn care procedure

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Age greater than or equal to 18 years * Compliant and able to complete questionnaires * No history of psychiatric disorder * Not demonstrating delirium, psychosis or any form of Organic Brain Disorder * Able to communicate verbally * English-speaking * IV access already in place

Exclusion criteria

* Age less than 18 years * Not capable of indicating pain intensity * Not capable of filling out study measures * Evidence of traumatic brain injury * History of psychiatric disorder * Demonstrating delirium, psychosis or any form of Organic Brain Disorder and associated memory problems * Unable to communicate orally * Receiving prophylaxis for alcohol or drug withdrawal * Developmental disability * Any face/head/neck injuries that interfere with the use of Virtual Reality equipment * Non-English Speaking * Extreme susceptibility to motion sickness * Seizure history * No IV access already in place

Design outcomes

Primary

Measure	Time frame
Graphic Rating Scale (GRS) is a questionnaire consists of three subjective pain ratings, one subjective anxiety rating, and one rating of fun using the 0-10.	1 day (Immediately following burn care )

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026